PCK3145, a novel multitargeted signalling agent for the treatment of castrate metastatic prostate cancer (CMPC)
Year: 2007
Type: article
Source: Molecular Cancer Therapeutics
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2279238297
